Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.22.2.2
Warrants
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Warrants Warrants
In January 2021, in connection with a Business Development Agreement entered into with Finback Evolv II, LLC (“Finback BDA”), the Company issued a warrant to Finback for the purchase of 2,552,913 shares of common stock at an exercise price of $0.42 per share. The 2021 Finback common stock warrants vest upon meeting certain sales criteria as defined in the agreement and expire in January 2031. The warrants will be accounted for under ASC 718 Compensation – Stock Compensation as the warrants will vest upon certain performance conditions being met (see Note 16).
In connection with the closing of the Merger, the Company assumed the Public Warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50. The Public Warrants are immediately exercisable and expire in July 2026. The Public Warrants are classified as a liability and recorded at their fair value of $23.6 million on the date of closing of the Merger with an offset to additional paid-in-capital and are subsequently remeasured to fair value at each reporting date based on the publicly available trading price. The change in fair value of the public warrant liability of $(0.1) million and $5.4 million for the three and six months ended June 30, 2022, respectively, was recognized as a component of other income (expense), net in the condensed consolidated statements of operations and comprehensive loss.
As of June 30, 2022 and December 31, 2021, warrants to purchase the following classes of Common Stock outstanding consisted of the following in the table below:
June 30, 2022
Issuance Date Contractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
January 13, 2021 10 Common stock Equity 2,552,913 $ 0.42
July 16, 2021 5 Common stock Liability 14,324,994 $ 11.50
    16,877,907
December 31, 2021
Issuance Date Contractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
January 13, 2021 10 Common stock Equity 2,552,913 $ 0.42
July 16, 2021 5 Common stock Liability 14,324,994 $ 11.50
16,877,907